Ocean Biomedical, Inc.
NASDAQ Global MarketTotal Valuation
Ocean Biomedical, Inc. carries a market capitalization of 20.40M, placing it among publicly traded companies globally.
| Market Cap | 20.40M |
| Enterprise Value | N/A |
Share Statistics
Ocean Biomedical, Inc. currently has 166.01M shares outstanding.
| Shares Outstanding | 166.01M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Ocean Biomedical, Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.06 |
| Quick Ratio | N/A |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -2.37 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1,356.85 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -5.47 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Ocean Biomedical, Inc.'s stock has gained approximately 12.45283% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 12.45283% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -4.16M, while operating income came in at -4.16M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -4.16M |
| Pretax Income | -30.72M |
| Net Income | -30.72M |
| EBITDA | -4.16M |
| EBIT | -4.16M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Total book value stands at -213.77M, with working capital of -25.08M providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 9.35M |
| Equity (Book Value) | -213.77M |
| Book Value Per Share | N/A |
| Working Capital | -25.08M |
Cash Flow
Ocean Biomedical, Inc. produced -4.05M in operating cash flow over the past twelve months.
| Operating Cash Flow | -4.05M |
| Capital Expenditures | N/A |
| Free Cash Flow | -4.05M |
| FCF Per Share | N/A |
Scores
Ocean Biomedical, Inc. posts an Altman Z-Score of -216.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -216.88 |